Seller record · Telehealth service
EmbraceRX
Fails 3 of 8 criteria. S2, prescription gating: The home page steps have the buyer pick a protocol before starting the assessment, and each product page says the buyer is charged the monthly price on the day the product is added, with any higher strength the clinician prescribes after the visit charged afterward. The answers instead say medication is billed when it ships. 2 more criteria also fail; see the table below.
At a glance
EmbraceRXTelehealth service
- Price
- Compounded semaglutide with B12 injection from $81 a month; compounded tirzepatide injection from $129.60 a month
- Sells
- compounded semaglutide with B12 injection, and 10 more
- FDA letters
- None on file
Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.
A Ventura, California telehealth platform selling compounded semaglutide and tirzepatide as injections and capsules, alongside a long catalog of compounded peptides such as BPC-157, sermorelin and GHK-Cu, prescribed online through an independent physician network.
Operating entity No legal entity name appears in the footer, on the contact page, in the terms or in the privacy policy, which name the operator only as EmbraceRX and its owners or affiliates.
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | EmbraceRX's website; EmbraceRX's FAQ |
| S2 | Prescription gating | FAIL | EmbraceRX's website; EmbraceRX's semaglutide B12 injection product page; EmbraceRX's FAQ |
| S3 | Pharmacy identification | FAIL | EmbraceRX's FAQ; EmbraceRX's terms of use page; EmbraceRX's weight loss category page |
| S4 | Compounding disclosure | PASS | EmbraceRX's weight loss category page; EmbraceRX's semaglutide B12 injection product page; EmbraceRX's semaglutide capsules product page |
| S5 | Analytical documentation | FAIL | EmbraceRX's semaglutide B12 injection product page; EmbraceRX's FAQ; EmbraceRX's terms of use page; EmbraceRX's returns and refund policy |
| S6 | Business address | PASS | EmbraceRX's contact page; EmbraceRX's terms of use page |
| S7 | Price disclosure | PASS | EmbraceRX's semaglutide B12 injection product page; EmbraceRX's tirzepatide injection product page; EmbraceRX's semaglutide capsules product page; EmbraceRX's tirzepatide capsules product page; EmbraceRX's BPC-157 injection product page; EmbraceRX's sermorelin injection product page |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: compounded semaglutide with B12 injection, compounded tirzepatide injection, semaglutide capsules, tirzepatide capsules, BPC-157 injection, CJC-1295 / ipamorelin, GHK-Cu injection, sermorelin injection, NAD+ injection, MOTS-C, epithalon.
Other sellers of the same products
Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells GHK-CuWho sells BPC-157Who sells MOTS-cWho sells epitalonWho sells ipamorelin
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.